Related Experiment Videos
Do single enantiomers have something special to offer?
1Division of Biomedical Sciences, Faculty of Medicine, Imperial College School of Medicine, London, UK.
Human Psychopharmacology
|October 31, 2002
Summary
Single enantiomers are increasingly vital in drug discovery, with fewer racemates reaching the market. Clinicians must understand chiral drugs as they become more prevalent in medicine.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Development
Background:
- Single enantiomers offer advantages in drug discovery and development.
- Advancements are overcoming technical challenges in single enantiomer development.
- Targeted drug development leads to more de novo single enantiomer drugs.
Purpose of the Study:
- To examine issues arising from the increasing importance of single enantiomers in medicine.
- To highlight the shift from racemic mixtures to single enantiomers in pharmaceutical development.
- To inform clinicians about the implications of chiral drugs in clinical practice.
Main Methods:
- Review of current trends in single enantiomer drug development.
- Analysis of patent literature concerning chiral switches.
- Examination of the impact of single enantiomers on the pharmaceutical market.
Main Results:
- Pharmaceutical companies are increasingly developing single enantiomers early in the drug pipeline.
- The market is seeing a decline in new racemic drugs, with a rise in single enantiomer drugs.
- Speculative patents for chiral switches indicate growing commercial interest.
Conclusions:
- Single enantiomers are poised to impact all areas of clinical medicine.
- The increasing prevalence of chiral drugs necessitates greater awareness among clinicians.
- Understanding the nuances of enantiomers is crucial for future medical practice.